HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ — Enginprime Medical Inc (“Enginprime”), an emerging leader in percutaneous…
Category: News
Taste of the Draft to Deliver Community Impact for Western Pennsylvania Children
GENYOUth, the NFL, Pittsburgh Steelers, VisitPITTSBURGH, PNC Bank, Pittsburgh Public Schools Announce Community Impact Initiative toSupport…
Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight
The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine…
Piramal Pharma Solutions démontre son engagement envers l’excellence avec un taux de recommandation net exceptionnel
Piramal Pharma Solutions a récemment obtenu un taux de recommandation net (TRN) de 55, dépassant de…
Piramal Pharma Solutions demonstriert Engagement für Spitzenleistungen mit hervorragendem Net Promoter Score
Piramal Pharma Solutions hat kürzlich einen Net Promoter Score (NPS) von 55 erreicht und damit den…
Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025
SAN FRANCISCO, Dec. 15, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused…
Star Ratings reset: How MA plans can prepare
As the 2025 calendar year closes out, Medicare Advantage (MA) leaders are continuing to evaluate the…
Rona Therapeutics Advances INHBE siRNA Into Phase 1 Clinical Development
SHANGHAI and SANTA BARBARA, Calif., Dec. 15, 2025 /PRNewswire/ — Rona Therapeutics, a clinical-stage RNAi company,…
AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ — USANewsGroup.comNews Commentary…
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave
Issued on behalf of Aleen Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ — Equity Insider News…